arrow
M

Maja Guberina

university of duisburg-essen
H指数:14
被引数:748

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recommendation of the DEGRO Head and Neck Cancer Working Group: proton versus photon radiotherapy for oropharyngeal cancer in the context of contradictory phase III evidence

德国放射肿瘤学会头颈肿瘤工作组建议:在存在矛盾性III期证据的背景下,关于口咽癌的质子放疗与光子放疗

2026-09-070
PRE
A multicenter analysis of prognostic factors for patients undergoing re-irradiation for recurrent glioblastoma

多中心分析复发性胶质母细胞瘤再放疗患者的预后因素

2026-09-020
OAAI
Ten-year Overall Survival in Resectable Stage-III NSCLC - Results of the Randomized ESPATUE Trial – Long-term Survival and Competing Risk Analysis
2026-02-040
PRE
Pathologic Complete Response Predicts Long-Term Survival Following Neoadjuvant Induction Chemotherapy and Chemo-Radiotherapy in Stage-III Non-Small Cell Lung Cancer

病理完全缓解预测III期非小细胞肺癌新辅助诱导化疗及放化疗后的长期生存率

2025-11-190
OAAI
[18F]FDG-PET/CT-based evaluation of tumor response kinetics during induction chemotherapy and concurrent radiochemotherapy in stage II - III small-cell lung cancer

[18F]FDG-PET/CT在评估Ⅱ期-Ⅲ期小细胞肺癌诱导化疗及同期放化疗期间肿瘤反应动力学中的应用

2025-11-170
OAAI
Response to: Commentary on Maja Guberina et al.’s study of dose response relation for optic nerve atrophy at low-dose rate brachytherapy of uveal melanoma

对Maja Guberina等人关于脉络膜黑色素瘤低剂量率近距离放射治疗中视神经萎缩剂量-反应关系研究的评论的回应

2025-06-130
PRE
Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE)
2024-08-281
OAAI
The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts

皮下异种移植在HNSCC个体化放疗中的价值: 稳健的基因签名与患者和异种移植的放疗结果相关

2024-02-010
OAAI